Invites Biocore Co., Ltd. (XKON:216400)

Market Cap	30.00B -30.5%
Revenue (ttm)	16.96B +96.2%
Net Income	667.63M
EPS	163.00
Shares Out	7.71M
PE Ratio	23.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,083
Average Volume	244
Open	3,995.00
Previous Close	3,995.00
Day's Range	3,400.00 - 3,995.00
52-Week Range	1,801.00 - 5,980.00
Beta	0.16
RSI	45.60
Earnings Date	n/a

About Invites Biocore

Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency tes...

• Industry: Testing Laboratories
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 216400

Financial Performance

In 2014, Invites Biocore's revenue was 16.96 billion, an increase of 29.35% compared to the previous year's 13.11 billion. Earnings were 667.63 million, a decrease of -17.76%.